Firstcare Gas Relief Simethicone 125 Mg Anti-gas Tablet, Chewable
NDC Package 71594-709-10

11-digit billing NDC: 71594070910

Package Information

Firstcare Gas Relief Simethicone 125 Mg Anti-gas (simethicone 125 mg) tablets is adults and children 12 years and older: take 1 or 2 chewables as needed after meals and at bedtime.do not exceed 4 chewables in 24 hours except under the advice and supervision of a physician. This formulation utilizes a tablet, chewable delivery system. Marketed by Uspharma Ltd, this product is identified by NDC 71594-709 and is authorized under FDA application M002.

Identification & Billing

NDC Package Code
71594-709-10
Package Description
100 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
71594070910
RxNorm Crosswalk
RxCUI: 314221 - simethicone 125 MG Chewable Tablet

Clinical Specifications

Proprietary Name
Firstcare Gas Relief Simethicone 125 Mg Anti-gas
Non-Proprietary Name
Simethicone 125 Mg
Substance Name
Dimethicone
Dosage Form
Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Adults and children 12 years and older: take 1 or 2 chewables as needed after meals and at bedtime.do not exceed 4 chewables in 24 hours except under the advice and supervision of a physician.

Regulatory & Marketing

Labeler Name
Uspharma Ltd
Product Type
Human Otc Drug
FDA Application #
M002
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-12-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71594-709-10 identifies a specific commercial package of 100 tablet, chewable in 1 bottle, plastic of Firstcare Gas Relief Simethicone 125 Mg Anti-gas, a human over the counter drug labeled by Uspharma Ltd. This tablet, chewable is formulated for oral use and contains dimethicone as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Uspharma Ltd on May 12, 2026. The current certification is valid through December 31, 2027.

How is this Uspharma Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71594070910. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
71594-709-10
11-Digit CMS (5-4-2)
71594-0709-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.